Author

Joan K. Moore

Observed name: Joan Moore

Observed institutions: WellSpan Health, WellSpan York Hospital

OpenAlex ID: A5087038776

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

2017 · Ethan Basch, Stephanie L. Pugh, et al. · International Journal of Radiation Oncology*Biology*Physics · 118

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

2022 · Ziad Bakouny, Chris Labaki, et al. · JAMA Oncology · 54

Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19

2023 · Shuchi Gulati, Chih-Yuan Hsu, et al. · JAMA Oncology · 10

Precision Oncology Core Data Model to Support Clinical Genomics Decision Making

2023 · Taxiarchis Botsis, Joseph C. Murray, et al. · JCO Clinical Cancer Informatics · 9

The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521

2022 · William A. Hall, Theodore G. Karrison, et al. · International Journal of Radiation Oncology*Biology*Physics · 5

Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma

2023 · Douglas B. Johnson, Michael B. Atkins, et al. · BMC Cancer · 2

COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium

2026 · Alaina J. Brown, Chih-Yuan Hsu, et al. · JCO oncology advances.

Works count: 7

Citation count: 198

H-index: 5

I10-index: 3